From bridging access to ensuring drug safety, public policies play a critical role in supporting research to create lifesaving treatments and cures. Innovative policy solutions ensure that the health care system keeps up with the pace of R&D to continually improve and yield results in the future.
After decades of helping to lower the mortality rate from pneumonia, tuberculosis and other types of infection, the medicines we rely on now face the growing threat of antimicrobial resistance.
A group of experts recently discussed the ways we can realign the U.S. health care system to improve access and affordability for patients.
In recent years, researchers have expanded the limits of science so quickly that methods of treatment thought to be impossible a decade ago are now a reality.
Experts and thought leaders touching every aspect of cancer came together for "Future Shapers: A New Era in Cancer Care", a conversation led by Axios and part of PhRMA's GoBoldly Campaign.
The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors
Investment is a key driver of innovation across all industries. However, investment is especially important to the research-intensive biopharmaceutical industry.